The trading price of Boston Scientific Corp (NYSE:BSX) floating lower at last check on current market day and closing at $104.68, -1.40% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 76.70. In examining the 52-week price action we see that the stock hit a 52-week high of $107.17 and a 52-week low of $71.88. Over the past month, the stock has gained 2.45% in value.
Boston Scientific Corp, whose market valuation is $154.87 billion at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest BSX has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned BSX a recommendation rating is 15. Out of them, 1 rate it a Hold, while 13 recommend Buy, whereas 1 assign an Overweight rating. 0 analyst(s) have tagged Boston Scientific Corp (BSX) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 5.48, which symbolizes a positive outlook. A quick review shows that BSX’s price is currently 0.28% off the SMA20 and 4.10% off the SMA50. The RSI metric on the 14-day chart is currently showing 55.94, and weekly volatility stands at 1.38%. When measured over the past 30 days, the indicator reaches 0.93%. Boston Scientific Corp (NYSE:BSX)’s beta value is currently sitting at 0.69, while the Average True Range indicator is currently displaying 2.11. With analysts defining $100-$130 as the low and high price targets, we arrive at a consensus price target of $117 for the trailing 12-month period. The current price is about 4.47% off the estimated low and -24.19% off the forecast high, based on this estimate. Investors will be thrilled if BSX’s share price rises to $117, which is the median consensus price. At that level, BSX’s share price would be -11.77% below current price.
To see how Boston Scientific Corp stock has been performing today in comparison to its peers in the industry, here are the numbers: BSX stock’s performance was -1.40% at last check in today’s session, and 40.74% in the past year. Boston Scientific Corp has a P/E ratio of 76.70.
An evaluation of the daily trading volume of Boston Scientific Corp (NYSE:BSX) indicates that the 3-month average is 8.41 million.
Currently, records show that 1.48 billion of the company’s shares remain outstanding. The insiders hold 0.41% of outstanding shares, whereas institutions hold 92.18%. However, since the stock’s price has seen 17.20% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
